5HT3 Receptor Antagonists Market, Global Outlook and Forecast 2022-2028

April 2022 | 62 pages | ID: 503E3F7D4ACAEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of 5HT3 Receptor Antagonists in Global, including the following market information:

Global 5HT3 Receptor Antagonists Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global 5HT3 Receptor Antagonists market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Dolasetron Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of 5HT3 Receptor Antagonists include Otsuka Pharmaceutical, MedKoo Biosciences, Cipla, Helsinn Healthcare SA, Sanofi, Roche Holding AG, Kyowa Kirin, Heron Therapeutics and GlaxoSmithKline and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the 5HT3 Receptor Antagonists companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global 5HT3 Receptor Antagonists Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global 5HT3 Receptor Antagonists Market Segment Percentages, by Type, 2021 (%)

• Dolasetron
• Granisetron
• Ondansetron
• Palonosetron

Global 5HT3 Receptor Antagonists Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global 5HT3 Receptor Antagonists Market Segment Percentages, by Application, 2021 (%)

• Hospital Pharmacy
• Drugstore
• Others

Global 5HT3 Receptor Antagonists Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global 5HT3 Receptor Antagonists Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies 5HT3 Receptor Antagonists revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies 5HT3 Receptor Antagonists revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Otsuka Pharmaceutical
• MedKoo Biosciences
• Cipla
• Helsinn Healthcare SA
• Sanofi
• Roche Holding AG
• Kyowa Kirin
• Heron Therapeutics
• GlaxoSmithKline
• Fortovia Therapeutics

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 5HT3 Receptor Antagonists Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global 5HT3 Receptor Antagonists Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL 5HT3 RECEPTOR ANTAGONISTS OVERALL MARKET SIZE

2.1 Global 5HT3 Receptor Antagonists Market Size: 2021 VS 2028
2.2 Global 5HT3 Receptor Antagonists Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top 5HT3 Receptor Antagonists Players in Global Market
3.2 Top Global 5HT3 Receptor Antagonists Companies Ranked by Revenue
3.3 Global 5HT3 Receptor Antagonists Revenue by Companies
3.4 Top 3 and Top 5 5HT3 Receptor Antagonists Companies in Global Market, by Revenue in 2021
3.5 Global Companies 5HT3 Receptor Antagonists Product Type
3.6 Tier 1, Tier 2 and Tier 3 5HT3 Receptor Antagonists Players in Global Market
  3.6.1 List of Global Tier 1 5HT3 Receptor Antagonists Companies
  3.6.2 List of Global Tier 2 and Tier 3 5HT3 Receptor Antagonists Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global 5HT3 Receptor Antagonists Market Size Markets, 2021 & 2028
  4.1.2 Dolasetron
  4.1.3 Granisetron
  4.1.4 Ondansetron
  4.1.5 Palonosetron
4.2 By Type - Global 5HT3 Receptor Antagonists Revenue & Forecasts
  4.2.1 By Type - Global 5HT3 Receptor Antagonists Revenue, 2017-2022
  4.2.2 By Type - Global 5HT3 Receptor Antagonists Revenue, 2023-2028
  4.2.3 By Type - Global 5HT3 Receptor Antagonists Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global 5HT3 Receptor Antagonists Market Size, 2021 & 2028
  5.1.2 Hospital Pharmacy
  5.1.3 Drugstore
  5.1.4 Others
5.2 By Application - Global 5HT3 Receptor Antagonists Revenue & Forecasts
  5.2.1 By Application - Global 5HT3 Receptor Antagonists Revenue, 2017-2022
  5.2.2 By Application - Global 5HT3 Receptor Antagonists Revenue, 2023-2028
  5.2.3 By Application - Global 5HT3 Receptor Antagonists Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global 5HT3 Receptor Antagonists Market Size, 2021 & 2028
6.2 By Region - Global 5HT3 Receptor Antagonists Revenue & Forecasts
  6.2.1 By Region - Global 5HT3 Receptor Antagonists Revenue, 2017-2022
  6.2.2 By Region - Global 5HT3 Receptor Antagonists Revenue, 2023-2028
  6.2.3 By Region - Global 5HT3 Receptor Antagonists Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America 5HT3 Receptor Antagonists Revenue, 2017-2028
  6.3.2 US 5HT3 Receptor Antagonists Market Size, 2017-2028
  6.3.3 Canada 5HT3 Receptor Antagonists Market Size, 2017-2028
  6.3.4 Mexico 5HT3 Receptor Antagonists Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe 5HT3 Receptor Antagonists Revenue, 2017-2028
  6.4.2 Germany 5HT3 Receptor Antagonists Market Size, 2017-2028
  6.4.3 France 5HT3 Receptor Antagonists Market Size, 2017-2028
  6.4.4 U.K. 5HT3 Receptor Antagonists Market Size, 2017-2028
  6.4.5 Italy 5HT3 Receptor Antagonists Market Size, 2017-2028
  6.4.6 Russia 5HT3 Receptor Antagonists Market Size, 2017-2028
  6.4.7 Nordic Countries 5HT3 Receptor Antagonists Market Size, 2017-2028
  6.4.8 Benelux 5HT3 Receptor Antagonists Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia 5HT3 Receptor Antagonists Revenue, 2017-2028
  6.5.2 China 5HT3 Receptor Antagonists Market Size, 2017-2028
  6.5.3 Japan 5HT3 Receptor Antagonists Market Size, 2017-2028
  6.5.4 South Korea 5HT3 Receptor Antagonists Market Size, 2017-2028
  6.5.5 Southeast Asia 5HT3 Receptor Antagonists Market Size, 2017-2028
  6.5.6 India 5HT3 Receptor Antagonists Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America 5HT3 Receptor Antagonists Revenue, 2017-2028
  6.6.2 Brazil 5HT3 Receptor Antagonists Market Size, 2017-2028
  6.6.3 Argentina 5HT3 Receptor Antagonists Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa 5HT3 Receptor Antagonists Revenue, 2017-2028
  6.7.2 Turkey 5HT3 Receptor Antagonists Market Size, 2017-2028
  6.7.3 Israel 5HT3 Receptor Antagonists Market Size, 2017-2028
  6.7.4 Saudi Arabia 5HT3 Receptor Antagonists Market Size, 2017-2028
  6.7.5 UAE 5HT3 Receptor Antagonists Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Otsuka Pharmaceutical
  7.1.1 Otsuka Pharmaceutical Corporate Summary
  7.1.2 Otsuka Pharmaceutical Business Overview
  7.1.3 Otsuka Pharmaceutical 5HT3 Receptor Antagonists Major Product Offerings
  7.1.4 Otsuka Pharmaceutical 5HT3 Receptor Antagonists Revenue in Global Market (2017-2022)
  7.1.5 Otsuka Pharmaceutical Key News
7.2 MedKoo Biosciences
  7.2.1 MedKoo Biosciences Corporate Summary
  7.2.2 MedKoo Biosciences Business Overview
  7.2.3 MedKoo Biosciences 5HT3 Receptor Antagonists Major Product Offerings
  7.2.4 MedKoo Biosciences 5HT3 Receptor Antagonists Revenue in Global Market (2017-2022)
  7.2.5 MedKoo Biosciences Key News
7.3 Cipla
  7.3.1 Cipla Corporate Summary
  7.3.2 Cipla Business Overview
  7.3.3 Cipla 5HT3 Receptor Antagonists Major Product Offerings
  7.3.4 Cipla 5HT3 Receptor Antagonists Revenue in Global Market (2017-2022)
  7.3.5 Cipla Key News
7.4 Helsinn Healthcare SA
  7.4.1 Helsinn Healthcare SA Corporate Summary
  7.4.2 Helsinn Healthcare SA Business Overview
  7.4.3 Helsinn Healthcare SA 5HT3 Receptor Antagonists Major Product Offerings
  7.4.4 Helsinn Healthcare SA 5HT3 Receptor Antagonists Revenue in Global Market (2017-2022)
  7.4.5 Helsinn Healthcare SA Key News
7.5 Sanofi
  7.5.1 Sanofi Corporate Summary
  7.5.2 Sanofi Business Overview
  7.5.3 Sanofi 5HT3 Receptor Antagonists Major Product Offerings
  7.5.4 Sanofi 5HT3 Receptor Antagonists Revenue in Global Market (2017-2022)
  7.5.5 Sanofi Key News
7.6 Roche Holding AG
  7.6.1 Roche Holding AG Corporate Summary
  7.6.2 Roche Holding AG Business Overview
  7.6.3 Roche Holding AG 5HT3 Receptor Antagonists Major Product Offerings
  7.6.4 Roche Holding AG 5HT3 Receptor Antagonists Revenue in Global Market (2017-2022)
  7.6.5 Roche Holding AG Key News
7.7 Kyowa Kirin
  7.7.1 Kyowa Kirin Corporate Summary
  7.7.2 Kyowa Kirin Business Overview
  7.7.3 Kyowa Kirin 5HT3 Receptor Antagonists Major Product Offerings
  7.7.4 Kyowa Kirin 5HT3 Receptor Antagonists Revenue in Global Market (2017-2022)
  7.7.5 Kyowa Kirin Key News
7.8 Heron Therapeutics
  7.8.1 Heron Therapeutics Corporate Summary
  7.8.2 Heron Therapeutics Business Overview
  7.8.3 Heron Therapeutics 5HT3 Receptor Antagonists Major Product Offerings
  7.8.4 Heron Therapeutics 5HT3 Receptor Antagonists Revenue in Global Market (2017-2022)
  7.8.5 Heron Therapeutics Key News
7.9 GlaxoSmithKline
  7.9.1 GlaxoSmithKline Corporate Summary
  7.9.2 GlaxoSmithKline Business Overview
  7.9.3 GlaxoSmithKline 5HT3 Receptor Antagonists Major Product Offerings
  7.9.4 GlaxoSmithKline 5HT3 Receptor Antagonists Revenue in Global Market (2017-2022)
  7.9.5 GlaxoSmithKline Key News
7.10 Fortovia Therapeutics
  7.10.1 Fortovia Therapeutics Corporate Summary
  7.10.2 Fortovia Therapeutics Business Overview
  7.10.3 Fortovia Therapeutics 5HT3 Receptor Antagonists Major Product Offerings
  7.10.4 Fortovia Therapeutics 5HT3 Receptor Antagonists Revenue in Global Market (2017-2022)
  7.10.5 Fortovia Therapeutics Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. 5HT3 Receptor Antagonists Market Opportunities & Trends in Global Market
Table 2. 5HT3 Receptor Antagonists Market Drivers in Global Market
Table 3. 5HT3 Receptor Antagonists Market Restraints in Global Market
Table 4. Key Players of 5HT3 Receptor Antagonists in Global Market
Table 5. Top 5HT3 Receptor Antagonists Players in Global Market, Ranking by Revenue (2021)
Table 6. Global 5HT3 Receptor Antagonists Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global 5HT3 Receptor Antagonists Revenue Share by Companies, 2017-2022
Table 8. Global Companies 5HT3 Receptor Antagonists Product Type
Table 9. List of Global Tier 1 5HT3 Receptor Antagonists Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 5HT3 Receptor Antagonists Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global 5HT3 Receptor Antagonists Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - 5HT3 Receptor Antagonists Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - 5HT3 Receptor Antagonists Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global 5HT3 Receptor Antagonists Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - 5HT3 Receptor Antagonists Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - 5HT3 Receptor Antagonists Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global 5HT3 Receptor Antagonists Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global 5HT3 Receptor Antagonists Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global 5HT3 Receptor Antagonists Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America 5HT3 Receptor Antagonists Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America 5HT3 Receptor Antagonists Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe 5HT3 Receptor Antagonists Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe 5HT3 Receptor Antagonists Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia 5HT3 Receptor Antagonists Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia 5HT3 Receptor Antagonists Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America 5HT3 Receptor Antagonists Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America 5HT3 Receptor Antagonists Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa 5HT3 Receptor Antagonists Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa 5HT3 Receptor Antagonists Revenue, (US$, Mn), 2023-2028
Table 30. Otsuka Pharmaceutical Corporate Summary
Table 31. Otsuka Pharmaceutical 5HT3 Receptor Antagonists Product Offerings
Table 32. Otsuka Pharmaceutical 5HT3 Receptor Antagonists Revenue (US$, Mn), (2017-2022)
Table 33. MedKoo Biosciences Corporate Summary
Table 34. MedKoo Biosciences 5HT3 Receptor Antagonists Product Offerings
Table 35. MedKoo Biosciences 5HT3 Receptor Antagonists Revenue (US$, Mn), (2017-2022)
Table 36. Cipla Corporate Summary
Table 37. Cipla 5HT3 Receptor Antagonists Product Offerings
Table 38. Cipla 5HT3 Receptor Antagonists Revenue (US$, Mn), (2017-2022)
Table 39. Helsinn Healthcare SA Corporate Summary
Table 40. Helsinn Healthcare SA 5HT3 Receptor Antagonists Product Offerings
Table 41. Helsinn Healthcare SA 5HT3 Receptor Antagonists Revenue (US$, Mn), (2017-2022)
Table 42. Sanofi Corporate Summary
Table 43. Sanofi 5HT3 Receptor Antagonists Product Offerings
Table 44. Sanofi 5HT3 Receptor Antagonists Revenue (US$, Mn), (2017-2022)
Table 45. Roche Holding AG Corporate Summary
Table 46. Roche Holding AG 5HT3 Receptor Antagonists Product Offerings
Table 47. Roche Holding AG 5HT3 Receptor Antagonists Revenue (US$, Mn), (2017-2022)
Table 48. Kyowa Kirin Corporate Summary
Table 49. Kyowa Kirin 5HT3 Receptor Antagonists Product Offerings
Table 50. Kyowa Kirin 5HT3 Receptor Antagonists Revenue (US$, Mn), (2017-2022)
Table 51. Heron Therapeutics Corporate Summary
Table 52. Heron Therapeutics 5HT3 Receptor Antagonists Product Offerings
Table 53. Heron Therapeutics 5HT3 Receptor Antagonists Revenue (US$, Mn), (2017-2022)
Table 54. GlaxoSmithKline Corporate Summary
Table 55. GlaxoSmithKline 5HT3 Receptor Antagonists Product Offerings
Table 56. GlaxoSmithKline 5HT3 Receptor Antagonists Revenue (US$, Mn), (2017-2022)
Table 57. Fortovia Therapeutics Corporate Summary
Table 58. Fortovia Therapeutics 5HT3 Receptor Antagonists Product Offerings
Table 59. Fortovia Therapeutics 5HT3 Receptor Antagonists Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. 5HT3 Receptor Antagonists Segment by Type in 2021
Figure 2. 5HT3 Receptor Antagonists Segment by Application in 2021
Figure 3. Global 5HT3 Receptor Antagonists Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global 5HT3 Receptor Antagonists Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global 5HT3 Receptor Antagonists Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by 5HT3 Receptor Antagonists Revenue in 2021
Figure 8. By Type - Global 5HT3 Receptor Antagonists Revenue Market Share, 2017-2028
Figure 9. By Application - Global 5HT3 Receptor Antagonists Revenue Market Share, 2017-2028
Figure 10. By Region - Global 5HT3 Receptor Antagonists Revenue Market Share, 2017-2028
Figure 11. By Country - North America 5HT3 Receptor Antagonists Revenue Market Share, 2017-2028
Figure 12. US 5HT3 Receptor Antagonists Revenue, (US$, Mn), 2017-2028
Figure 13. Canada 5HT3 Receptor Antagonists Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico 5HT3 Receptor Antagonists Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe 5HT3 Receptor Antagonists Revenue Market Share, 2017-2028
Figure 16. Germany 5HT3 Receptor Antagonists Revenue, (US$, Mn), 2017-2028
Figure 17. France 5HT3 Receptor Antagonists Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. 5HT3 Receptor Antagonists Revenue, (US$, Mn), 2017-2028
Figure 19. Italy 5HT3 Receptor Antagonists Revenue, (US$, Mn), 2017-2028
Figure 20. Russia 5HT3 Receptor Antagonists Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries 5HT3 Receptor Antagonists Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux 5HT3 Receptor Antagonists Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia 5HT3 Receptor Antagonists Revenue Market Share, 2017-2028
Figure 24. China 5HT3 Receptor Antagonists Revenue, (US$, Mn), 2017-2028
Figure 25. Japan 5HT3 Receptor Antagonists Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea 5HT3 Receptor Antagonists Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia 5HT3 Receptor Antagonists Revenue, (US$, Mn), 2017-2028
Figure 28. India 5HT3 Receptor Antagonists Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America 5HT3 Receptor Antagonists Revenue Market Share, 2017-2028
Figure 30. Brazil 5HT3 Receptor Antagonists Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina 5HT3 Receptor Antagonists Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa 5HT3 Receptor Antagonists Revenue Market Share, 2017-2028
Figure 33. Turkey 5HT3 Receptor Antagonists Revenue, (US$, Mn), 2017-2028
Figure 34. Israel 5HT3 Receptor Antagonists Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia 5HT3 Receptor Antagonists Revenue, (US$, Mn), 2017-2028
Figure 36. UAE 5HT3 Receptor Antagonists Revenue, (US$, Mn), 2017-2028
Figure 37. Otsuka Pharmaceutical 5HT3 Receptor Antagonists Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. MedKoo Biosciences 5HT3 Receptor Antagonists Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Cipla 5HT3 Receptor Antagonists Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Helsinn Healthcare SA 5HT3 Receptor Antagonists Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Sanofi 5HT3 Receptor Antagonists Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Roche Holding AG 5HT3 Receptor Antagonists Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Kyowa Kirin 5HT3 Receptor Antagonists Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Heron Therapeutics 5HT3 Receptor Antagonists Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. GlaxoSmithKline 5HT3 Receptor Antagonists Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Fortovia Therapeutics 5HT3 Receptor Antagonists Revenue Year Over Year Growth (US$, Mn) & (2017-2022)